905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I

The impact of day of admission on morbidity and mortality outcomes on patients with febrile neutropenia in the United States A nationwide analysis

Correlates of breakthrough bleeding and emicizumab plasma levels in patients with hemophilia A

Complement inhibitor use is not a significant predictor of cancer incidence A real world study of patients requiring chronic complement blockade

The global PNH patient registry   real world data on PNH symptom burden and quality of life

Double jeopardy Heart failure and thrombotic thrombocytopenic purpura in the inpatient setting

Mortality associated with warm autoimmune hemolytic anemia among Medicare beneficiaries

It s that time of the month Menstrual suppression among adolescents and young adults with cancer and quality of life

Adolescent cardiovascular kidney metabolic health and estrogen exposure A cross sex gender inclusive cohort analysis

Evaluation of a newly formulated intranasal desmopressin versus intranasal and subcutaneous desmopressin in individuals with type 1 von Willebrand disease and mild Hemophilia A

Venous thromboembolism in multiple myeloma patients treated with BCMA directed CAR T cell therapy A systematic review and meta analysis

External validation of the intermountain risk scores for post discharge PD thrombosis and bleeding in an independent population

Real world treatment patterns outcomes among patients with immune thrombocytopenia ITP who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States Results from the real AVA 3 5 study

Thrombotic and hemorrhagic events and their impact on mortality among adults with newly diagnosed acute myeloid leukemia

Overall survival OS in patients with metastatic colorectal cancer mCRC following persistent chemotherapy induced thrombocytopenia pCIT

Relationship of sociodemographic factors to presentation and natural history of provoked venous thromboembolism in u s children A secondary analysis of the multinational kids DOTT trial

Understanding unmet needs for people with haemophilia a receiving factor and non factor treatments

Chinese pediatric cGvHD patients and caregivers perspectives Patient journey and trial participation

Evaluation for non accidental trauma NAT and bleeding disorders in infants referred to pediatric hematology